Skip to content
Home
Science
Our Approach
Oncology
Arthritis
Inflammatory Bowel Disease
Company
About Us
Our Name
Our Team
News
In the News
Press Releases
Publications
Contact
Menu
Home
Science
Our Approach
Oncology
Arthritis
Inflammatory Bowel Disease
Company
About Us
Our Name
Our Team
News
In the News
Press Releases
Publications
Contact
Albatroz Therapeutics
In the News
11/07/2023
Albatroz Co-Founder and CEO, Dr. Fredric Bard is spotlighted by A*STAR – Agency for Science, Technology and Research for his insights as a scientist-entrepreneur
10/18/2023
Albatroz Named One of Six Companies Leading Singapore’s Biotech Scene
10/10/2023
Albatroz Featured in the Novo Nordisk Singapore Partnering Day 2023
09/12/2023
Albatroz Co-Founder Presents at the ‘Biomedical Innovation in Asia’ Workshop
07/05/2023
In Vivo Spotlights Albatroz’s Science and the Leadership of Guy Heathers
06/07/2023
BioWorld Recognizes Albatroz Science, Leadership, and Progress Toward Blocking a Highly Specific Target to Block Growth and Spread of Solid Tumors and Cartilage Degradation
04/06/2023
Albatroz Therapeutics Featured in A *STAR Research Highlights
11/11/2020
Albatroz Therapeutics Selected as Finalist in the 2020 Brace Award Venture Competition
